The historical rank and industry rank for PRA Health Sciences's Net Margin % or its related term are showing as below:
PRAH'
s Net Margin % Range Over the Past 10 Years
Min: -2.45 Med: 4.46 Max: 7.93
Current: 6.36
PRAH's Net Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -11.145
vs PRAH: 6.36
PRA Health Sciences Net Margin % Historical Data
The historical data trend for PRA Health Sciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PRA Health Sciences's Net Margin %
For the Diagnostics & Research subindustry, PRA Health Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRA Health Sciences's Net Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PRA Health Sciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where PRA Health Sciences's Net Margin % falls into.
PRA Health Sciences Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
PRA Health Sciences's Net Margin for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRA Health Sciences (NAS:PRAH) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PRA Health Sciences Net Margin % Related Terms
Thank you for viewing the detailed overview of PRA Health Sciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
PRA Health Sciences (PRA Health Sciences) Business Description
PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. PRA's competitor, Icon, announced it will acquire PRA for $12 billion, which is scheduled to close in third-quarter 2021.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRAH has been successfully added to your 